Keine Story von Aion Therapeutic Inc. mehr verpassen.

Aion Therapeutic Inc.

  • 18.05.2021 – 17:20

    Combined Apollon and Aion Formulations Kill Breast Cancer Cells Through Multiple Pathways

    London and Toronto (ots/PRNewswire) - Apollon Formularies plc (AQSE: APOL) ("Apollon" or the "Company"), a UK based international pharmaceutical company trading on the Aquis Stock Exchange, and Aion Therapeutic Inc. (CSE: AION) ("Aion"), a BC based international pharmaceutical company trading on the Canadian Securities Exchange, are pleased to announce that joint ...

  • 11.03.2021 – 15:02

    Aion Therapeutic Files 4 New Patent Applications (Including for the Treatment of Human Cancers)

    Toronto (ots/PRNewswire) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") announced today that it has filed 4 new patent applications related to preparations of medicinal and psychedelic mushrooms. The patent applications include use of medicinal mushrooms for the treatment of human cancers including breast cancer, use of combination medical ...